Bridging Disciplines to Understand the Impact of Prenatal Medication Exposure on Child Development

SEMINAR: How can researchers discover the long-term effects of prenatal medication exposure on children’s lives when randomized studies are not an option?

Kristina Gervin, Hedvig Nordeng, and Janne von Koss Torkildsen. Photomontage

Hedvig Nordeng (left), Kristina Gervin, and Janne von Koss Torkildsen. Photomontage: Shane Colvin

Speakers and topic

You will meet Professor Hedvig Nordeng, Department of Pharmacy; Senior Researcher Kristina Gervin, Oslo University Hospital; and Professor Janne von Koss Torkildsen, CREATE.

In their talk, they will present the UiO:Life Science convergence environment RealArt.

By uniting researchers across traditional disciplines (pharmacy, special needs education, psychology,(epi)genetics, and machine learning), the primary objective of this project is to improve causal inference in studies of medication safety on cognitive and academic outcomes in children.

How to draw causal inferences

The speakers will give examples of how they use data from existing cohort studies and registries to determine the impact of prenatal exposure to medications on language development, educational attainment and childhood psychological disorders.

Further, they will show how they explore the role of genetics and epigenetics on these exposure-outcomes associations, and how these analyses can strengthen reserachers' ability to draw causal inferences.

Tags: CREATE, seminar
Published Mar. 21, 2024 10:23 AM - Last modified Mar. 22, 2024 9:08 AM